Actionnariat et activité des initiés pour Bionano Genomics, Inc. (BNGO): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $1.51 |
| Capitalisation | $17M |
| Bourse | NASDAQ |
| Pays | US |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $5.2M | $1.0M | $16.5M | $17.3M | $38.4M | $24.6M | $5.1M | $17.9M | $9.2M | $3.0M |
| Placements à Court Terme | 0 | 0 | 0 | 0 | 0 | $226.0M | $108.1M | $48.8M | $302000 | $10.3M |
| Créances | $1.8M | $3.4M | $4.5M | $6.3M | $2.8M | $5.3M | $7.5M | $9.7M | $4.8M | $5.2M |
| Stocks | $1.8M | $1.7M | $1.1M | $3.4M | $3.3M | $12.4M | $29.8M | $22.9M | $11.1M | $5.4M |
| Actifs Courants | $10.7M | $7.1M | $23.0M | $28.3M | $46.8M | $272.4M | $157.3M | $140.1M | $39.5M | $45.4M |
| Immobilisations Corporelles | $4.1M | $3.0M | $1.8M | $1.9M | $4.9M | $20.9M | $29.0M | $32.5M | $24.3M | $21.2M |
| Goodwill | 0 | 0 | 0 | 0 | $7.2M | $56.2M | $77.3M | 0 | 0 | 0 |
| Actifs Incorporels | 0 | 0 | 0 | 0 | $1.5M | $26.8M | $41.1M | $34.0M | $9.7M | $4.3M |
| Actifs Totaux | $14.8M | $10.1M | $24.8M | $30.2M | $60.5M | $377.1M | $307.5M | $214.4M | $76.7M | $73.6M |
| Dettes Fournisseurs | $792332 | $2.3M | $1.4M | $2.7M | $2.9M | $10.8M | $12.5M | $10.4M | $7.0M | $5.6M |
| Dette à Court Terme | $587131 | $6.7M | 0 | $20.1M | 0 | 0 | 0 | $69.8M | $20.4M | 0 |
| Passifs Courants | $9.4M | $16.7M | $4.5M | $26.4M | $8.9M | $21.8M | $35.9M | $100.0M | $37.3M | $22.9M |
| Dette à Long Terme | $6.0M | 0 | $9.0M | 0 | $16.3M | 0 | 0 | 0 | 0 | $6.0M |
| Passifs Totaux | $42.0M | $60.4M | $14.7M | $26.6M | $25.4M | $40.0M | $58.1M | $118.2M | $41.3M | $29.2M |
| Réserves | -$30.9M | -$54.3M | -$72.8M | -$102.6M | -$143.7M | -$216.1M | -$348.7M | -$581.2M | -$693.2M | -$719.6M |
| Capitaux Propres | -$27.3M | -$50.2M | $10.1M | $3.6M | $35.1M | $337.1M | $249.4M | $96.2M | $35.4M | $44.4M |
| Dette Totale | $6.6M | $6.7M | $9.0M | $20.1M | $16.3M | $10.7M | $11.7M | $79.4M | $27.3M | $6.9M |
| Dette Nette | $1.4M | $5.7M | -$7.5M | $2.8M | -$22.1M | -$239.9M | -$101.5M | $12.6M | $17.8M | -$6.3M |
| Fonds de Roulement | $1.4M | -$9.5M | $18.5M | $1.9M | $37.8M | $250.6M | $121.4M | $40.1M | $2.1M | $22.4M |
Santé financière
| Dette / Capitaux propres | 0.21 |
| Ratio de liquidité | 2.48 |
| Piotroski F-Score | 4 |
| Altman Z-Score | -14.26 |
Rentabilité
| Rentabilité des capitaux propres | -78.78% |
| Rentabilité du capital investi | -83.76% |
| Rentabilité des actifs | -67.58% |
| Marge brute | 47.50% |
| Marge opérationnelle | -106.67% |
| Marge nette | -106.58% |
Entreprises liées: AIM · BNBX · GBS · KTTA · MYNZ · NDRA · POAI
Explorer le secteur: Healthcare · Medical - Instruments & Supplies
Plus de sections de BNGO: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions